R01 DE021139/DE/NIDCR NIH HHS/United States[Grants and Funding] - Search Results

Year	Number of Results
2011	5
2012	9
2013	9
2014	5
2015	3
2016	9
2017	5
2018	7
2019	1
2020	3
2021	7
2022	3
2023	3
2024	0

1

Systemic therapies for salivary gland adenoid cystic carcinoma.

Sahara S, Herzog AE, Nör JE. Sahara S, et al. Am J Cancer Res. 2021 Sep 15;11(9):4092-4110. eCollection 2021. Am J Cancer Res. 2021. PMID: 34659878 Free PMC article. Review.

2

Modeling head and neck cancer stem cell-mediated tumorigenesis.

Pearson AT, Jackson TL, Nör JE. Pearson AT, et al. Cell Mol Life Sci. 2016 Sep;73(17):3279-89. doi: 10.1007/s00018-016-2226-x. Epub 2016 May 5. Cell Mol Life Sci. 2016. PMID: 27151511 Free PMC article. Review.

3

p53 and Cell Fate: Sensitizing Head and Neck Cancer Stem Cells to Chemotherapy.

Rodriguez-Ramirez C, Nör JE. Rodriguez-Ramirez C, et al. Crit Rev Oncog. 2018;23(3-4):173-187. doi: 10.1615/CritRevOncog.2018027353. Crit Rev Oncog. 2018. PMID: 30311573 Free PMC article. Review.

4

Head and neck cancer stem cells.

Krishnamurthy S, Nör JE. Krishnamurthy S, et al. J Dent Res. 2012 Apr;91(4):334-40. doi: 10.1177/0022034511423393. Epub 2011 Sep 20. J Dent Res. 2012. PMID: 21933937 Free PMC article. Review.

5

Bmi-1: A master regulator of head and neck cancer stemness.

Herzog AE, Somayaji R, Nör JE. Herzog AE, et al. Front Oral Health. 2023 Jan 16;4:1080255. doi: 10.3389/froh.2023.1080255. eCollection 2023. Front Oral Health. 2023. PMID: 36726797 Free PMC article. Review.

6

Therapeutic inhibition of Bmi-1 ablates chemoresistant cancer stem cells in adenoid cystic carcinoma.

Sahara S, Warner KA, Herzog AE, Zhang Z, Nör JE. Sahara S, et al. Oral Oncol. 2023 Jul;142:106437. doi: 10.1016/j.oraloncology.2023.106437. Epub 2023 May 31. Oral Oncol. 2023. PMID: 37267716

7

Crosstalk between cancer stem cells and the tumor microenvironment drives progression of premalignant oral epithelium.

Polverini PJ, Nör F, Nör JE. Polverini PJ, et al. Front Oral Health. 2023 Jan 10;3:1095842. doi: 10.3389/froh.2022.1095842. eCollection 2022. Front Oral Health. 2023. PMID: 36704239 Free PMC article. Review.

8

mTOR Inhibition Ablates Cisplatin-Resistant Salivary Gland Cancer Stem Cells.

Nakano T, Warner KA, Oklejas AE, Zhang Z, Rodriguez-Ramirez C, Shuman AG, Nör JE. Nakano T, et al. J Dent Res. 2021 Apr;100(4):377-386. doi: 10.1177/0022034520965141. Epub 2020 Oct 17. J Dent Res. 2021. PMID: 33073679 Free PMC article.

9

p53 Inhibits Bmi-1-driven Self-Renewal and Defines Salivary Gland Cancer Stemness.

Rodriguez-Ramirez C, Zhang Z, Warner KA, Herzog AE, Mantesso A, Zhang Z, Yoon E, Wang S, Wicha MS, Nör JE. Rodriguez-Ramirez C, et al. Clin Cancer Res. 2022 Nov 1;28(21):4757-4770. doi: 10.1158/1078-0432.CCR-22-1357. Clin Cancer Res. 2022. PMID: 36048559 Free PMC article.

10

Perivascular stem cell niche in head and neck cancer.

Ritchie KE, Nör JE. Ritchie KE, et al. Cancer Lett. 2013 Sep 10;338(1):41-6. doi: 10.1016/j.canlet.2012.07.025. Epub 2012 Jul 25. Cancer Lett. 2013. PMID: 22842095 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

55 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

55 results

Results by year